Does the efficacy of different doses of Botulinum neurotoxin in chronic migraine change in terms of age and sex?

Journal Title: Gulhane Medical Journal - Year 2020, Vol 62, Issue 1

Abstract

Aim: The aim of this study was to investigate the effectiveness of Botulinum toxin A (BoNTA) treatment at different doses according to age and sex. Methods: In this study, 53 patients diagnosed as chronic migraine (CM) were evaluated. The patients were divided into four groups. Group 1a (n=13) were elderly patients who received 5 U BoNTA. Group 1b (n=13) were elderly patients who received 2.5 U BoNTA. Group 2a (n=14) were young patients who received 5 U BoNTA. Group 2b (n=13) were young patients who received 2.5 U BoNTA. In all patients, the number of headache days and the severity of pain were compared before and after the treatment. Results: There was a statistically significant difference between the number of headache days and the severity of pain in group 1a, group 1b, and group 2a at 3-month post-treatment (p<0.05). In the comparison between the groups, there was a statistically significant decrease in pain intensity in group 1b compared to group 2b in which 2.5 U BoNTA was applied (p<0.05). Conclusion: In the treatment of CM, 5 U BoNTA applications were found to be an effective treatment method in both young and old population. However, the efficacy of 2.5 U of BoNTA treatment was seen to be superior in the elderly population compared to the younger population.

Authors and Affiliations

Akçay Övünç Özön

Keywords

Related Articles

The awareness of chronic obstructive pulmonary disease among smokers admitting to pulmonary medicine outpatient clinic: Single center experience

Aims: Smoking is the strongest risk factor for chronic obstructive pulmonary disease (COPD), but the awareness of COPD among smokers has been found at low levels worldwide. The aim of current study was to assess the COPD...

Importance of complete blood count parameters and neutrophil-to-lymphocyte ratio in central and peripheral vertigo

Aim: The present study investigated the diagnostic value of complete blood count (CBC) parameters, neutrophil-to-lymphocyte (NLR), mean platelet volume-to-platelet (MPV/PLT), and platelet-to-lymphocyte (PLR) ratios in pa...

Is mitral balloon valvuloplasty really innocent?: A case report of right ventricular rupture

Percutaneous mitral balloon valvuloplasty (PMBV) is the primary treatment modality in patients with mitral stenosis without contraindications and with appropriate valve anatomy. In the literature, the mortality rate asso...

Immunohistochemistry expression of EMA, CD10, CEA, and Bcl-2 in distinguishing cutaneous basal cell from squamous cell carcinoma: A systematic review

Cutaneous basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most popular neoplastic entities in cutaneous medicine. These two neoplasms are commonly well recognized on the basis of their clinical and h...

Absolute lymphocyte count is a predictor of outcome after splenectomy for immune thrombocytopenia

Aims: Splenectomy is still the standard salvage therapy in immune thrombocytopenia (ITP) cases refractory to corticosteroid therapy. The aim of this study was to evaluate adult ITP patients who underwent splenectomy and...

Download PDF file
  • EP ID EP684395
  • DOI 10.4274/gulhane.galenos.2020.928
  • Views 197
  • Downloads 0

How To Cite

Akçay Övünç Özön (2020). Does the efficacy of different doses of Botulinum neurotoxin in chronic migraine change in terms of age and sex?. Gulhane Medical Journal, 62(1), -. https://europub.co.uk/articles/-A-684395